Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10256/3471

Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project
Marcos-Gragera, Rafael; Allemani, Claudia; Tereanu, Carmen; De Angelis, Roberta; Capocaccia, Riccardo; Maynadie, Marc; Luminari, Stefano; Ferretti, Stefano; Johannesen, Tom Børge; Sankila, Risto; Karjalainen-Lindsberg, Marja-Liisa; Simonetti, Arianna; Martos Jiménez, Mª Carmen; Raphael, Martine; Giraldo, Pilar; Sant, Milena
The European Cancer Registry-based project on hematologic malignancies (HAEMACARE), setup to improve the availability and standardization of data on hematologic malignancies in Europe, used the European Cancer Registry-based project on survival and care of cancer patients (EUROCARE-4) database to produce a new grouping of hematologic neoplasma(defined by the International Classification of Diseases for Oncology, Third Edition and the 2001/2008 World Health Organization classifications) for epidemiological and public healthpurposes. We analyzed survival for lymphoid neoplasms in Europe by disease group, comparing survival between different European regions by age and sex. Design and Methods Incident neoplasms recorded between 1995 to 2002 in 48 population-based cancer registries in 20 countries participating in EUROCARE-4 were analyzed. The period approach was used to estimate 5-year relative survival rates for patients diagnosed in 2000-2002, who did not have 5years of follow up. Results: The 5-year relative survival rate was 57% overall but varied markedly between the definedgroups. Variation in survival within the groups was relatively limited across European regions and less than in previous years. Survival differences between men and women were small. The relative survival for patients with all lymphoid neoplasms decreased substantially after the age of 50. The proportion of ‘not otherwise specified’ diagnoses increased with advancing age.Conclusions: This is the first study to analyze survival of patients with lymphoid neoplasms, divided into groups characterized by similar epidemiological and clinical characteristics, providing a benchmarkfor more detailed analyses. This Europe-wide study suggests that previously noted differences in survival between regions have tended to decrease. The survival of patients with all neoplasms decreased markedly with age, while the proportion of ‘not otherwise specified’ diagnoses increased with advancing age. Thus the quality of diagnostic work-up and care decreased with age, suggesting that older patients may not be receiving optimal treatment
Limfomes
Tumors
Lymphomas
Tots els drets reservats
Artículo
info:eu-repo/semantics/publishedVersion
Ferrara Storti Foundation
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Feja Solana, Cristina; Alcalá Nalvaiz, J Tomás; Rabanaque Hernández, Mª José; Sáez Zafra, Marc; Marcos-Gragera, Rafael; Martos Jiménez, Mª Carmen
Lacasta Palacio, Ana María; Giraldo, Pilar; Avellaneda Diaz-Grande, Jaime; Burgos Leiva, Camila
Puigpinós Riera, Rosa; Mari Dell’Olmo, Marc; Gotsens, Mercè; Borrell, Carme; Serral, Gemma; Ascaso, Carlos; Calvo, Montse; Daponte, Antonio; Domínguez Berjón, Felicitas M.; Esnaola, Santiago; Gandarillas, Ana; López-Abente Ortega, Gonzalo; Martos Jiménez, Mª Carmen; Martínez Beneyto, Miguel A.; Montoya, Imanol; Nolasco, Andreu; Pasarín, Isabel M.; Rodríguez Sanz, Maica; Sáez Zafra, Marc; Sánchez Villegas, Pablo
Puigpinós Riera, Rosa; Mari Dell’Olmo, Marc; Gotsens, Mercè; Borrell, Carme; Serral, Gemma; Ascaso, Carlos; Calvo, Montse; Daponte, Antonio; Domínguez Berjón, Felicitas M.; Esnaola, Santiago; Gandarillas, Ana; López-Abente Ortega, Gonzalo; Martos Jiménez, Mª Carmen; Martínez Beneyto, Miguel A.; Montoya, Imanol; Nolasco, Andreu; Pasarín, Isabel M.; Rodríguez Sanz, Maica; Sáez Zafra, Marc; Sánchez Villegas, Pablo
Vilaprinyo, Ester; Rué, Montserrat; Marcos-Gragera, Rafael; Martínez-Alonso, Montserrat